• Connect with us
  • Information
    • About Us
    • Contact Us
    • Careers
    • Partnerships
    • Advertise With Us
    • Authors
    • Browse Topics
    • Events
    • Disclaimer
    • Privacy Policy
  • NORTH AMERICA EDITION
    Australia
    North America
    World
Login
Investing News NetworkYour trusted source for investing success
  • NORTH AMERICA EDITION
    North America
    Australia
    World
  • My INN
Videos
Companies
Press Releases
Private Placements
SUBSCRIBE
  • Reports & Guides
    • Market Outlook Reports
    • Investing Guides
  • Button
Resource
  • Precious Metals
  • Battery Metals
  • Base Metals
  • Energy
  • Critical Minerals
Tech
Life Science
Pharmaceutical Market
Pharmaceutical News
Pharmaceutical Stocks
  • Pharmaceutical Market
  • Pharmaceutical News
  • Pharmaceutical Stocks
pharmaceutical investing

CVS Health Executive Vice President and CFO interviewed by Advisor Access

Bryan Mc Govern
Feb. 28, 2017 10:52AM PST
Pharmaceutical Investing

CVS Health (NYSE:CVS) Dave Denton, Executive Vice President and CFO of the company, was interviewed by Advisor Access on all aspects of the company and its focus.

CVS Health (NYSE:CVS) Dave Denton, Executive Vice President and CFO of the company, was interviewed by Advisor Access on all aspects of the company and its focus.
As quoted in the press release:

Advisor Access: CVS Health has been focused on the theme of driving more affordable, accessible, and effective care. Can you talk about how you are executing on each of those objectives?
Dave Denton: As the healthcare market continues to evolve, healthcare stakeholders are placing increased emphasis on making care more affordable, accessible, and effective. We believe no other company has the full suite of assets to deliver on each of these objectives. We’ve built the capabilities to integrate pharmacy care from the payer to the provider to the patient…
AA: Drug pricing has been in the news repeatedly over the last year. How is CVS approaching this issue?
DD: One of the biggest and most complex challenges facing the healthcare system is the increasing cost of medications. Price inflation on established branded products, as well as new specialty products coming to market at elevated price points, are creating new challenges for plan sponsors and patients alike…
Read the complete answers to these questions and the full interview with CVS, HERE.
About Advisor Access:
Advisor Access LLC brings compelling investment ideas to investors in the form of in-depth interviews with company management and the latest fact sheets and corporate presentations.

Click here for full press release.

drug pricing pharmaceutical investing
The Conversation (0)

Go Deeper

AI Powered
Various colorful pills and tablets scattered from a brown bottle on a blue background.

Pharma Market Forecast: Top Trends for Pharma in 2026

Pharma Outlook

Pharma Outlook

Latest News

Outlook Reports

Resource
  • Precious Metals
    • Gold
    • Silver
  • Battery Metals
    • Lithium
    • Cobalt
    • Graphite
    • Electric Vehicles
  • Agriculture
  • Base Metals
    • Copper
    • Nickel
    • Zinc
  • Critical Metals
    • Rare Earths
  • Energy
    • Uranium
    • Oil and Gas
Tech
    • Artificial Intelligence
    • Cybersecurity
    • Robotics
    • Crypto
    • Cleantech
Life Science
    • Biotech
    • Cannabis
    • Pharmaceuticals

Featured Pharmaceutical Investing Stocks

InMed Pharmaceuticals

InMed Pharmaceuticals (INM)
INM

Cardiol Therapeutics

Cardiol Therapeutics (CRDL:CC)
CRDL:CC

Principal Technologies

Principal Technologies (PTEC:CC)
PTEC:CC
More featured stocks

Browse Companies

Resource
  • Precious Metals
  • Battery Metals
  • Energy
  • Base Metals
  • Critical Metals
Tech
Life Science
MARKETS
COMMODITIES
CURRENCIES